GFAP and central nervous system cancer: The majority of the patients (323 of 367, 88%) had GFAP positive (+), and 327 patients with low expression GFAP (90%), combined with four that scored (−), were distributed all over the gliomas grades, including low grade (132, 40%), and high grade (195, 60%).